8. Somatus: $325 million (HealthTech)Somatus provides individualized clinical, emotional and social support to kidney care patients through partnerships with nephrology groups, primary care groups and health plans and systems.
The MacLean, Virginia-based company developed the proprietary RenalIQ platform to track patient health and identify at-risk patients using predictive analytics and machine learning algorithms. The platform also offers telehealth and virtual care services, educational resources and real-time cost and utilization insights for providers.
Somatus was founded in 2015 and is led by co-founder and CEO Dr. Ikenna Okezie.
“Since our inception, Somatus has always been committed to bringing superior evidence-based integrated care to patients with kidney disease, which delays disease progression, improves quality of life, and lowers total cost of care,” Okezie said when announcing the Series E funding round. “This investment puts us in a great position to fund the expansion of our proven care model and continue building a nationwide network of providers and connected patients, who alongside our care teams are working together to improve lives and transform the industry.”